The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Accelerator™ Drug Development solutions support your aspiration to get treatments to patients faster.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Optimizing clinical supply management with a one-team approach
This clinical supply management case study shows how NewAmsterdam Pharma supported 11 studies (including three Phase III trials) across 51 countries while maintaining on-time clinical supply execution.
Managing global clinical supply for large, late-phase trials requires accurate forecasting, regulatory coordination, and reliable logistics across regions. In this case study, NewAmsterdam Pharma partnered with Patheon™ to support a complex clinical program spanning 11 studies, 51 countries, and 835 clinical sites, while minimizing operational burden and maintaining supply continuity for patients worldwide.
Results at a glance
- ~50% cost reduction compared to traditional clinical supply models
- 100% on-time delivery of 175,000+ clinical kits
- Supply support for 12,000+ patients across 835 clinical sites
- Global execution across 51 countries with consistent delivery performance
How the one-team approach supported global clinical supply
- Forecasting and demand planning using advanced simulation tools to reduce overproduction and shortages
- Streamlined regulatory navigation, including documentation and submission support across countries
- Accelerator™ Drug Development model to reduce operational handoffs and align cross-functional execution
- Global logistics network with regional depots to support reliable, on-time distribution
- Resource optimization to minimize internal sponsor workload
